Gebelikte Tromboembolik Hastalıklar

Yazarlar

Mucize Eriç Özdemir
https://orcid.org/0000-0002-2177-0771

Özet

Gebelik ve lohusalık dönemleri, venöz tromboemboli (VTE) riskini 4-50 kat artıran önemli süreçlerdir ve derin ven trombozu (DVT), pulmoner emboliden (PE) üç kat daha sık görülür. PE, gelişmiş ülkelerdeki anne ölümlerinin yedinci sıradaki nedenidir. Postpartum dönemde VTE riski ilk altı haftada en yüksek seviyededir. Kalıtımsal trombofili, geçirilmiş VTE öyküsü, sezaryen doğum, obezite ve ileri anne yaşı başlıca risk faktörleri arasında yer alır. Gebelikte DVT tanısında proksimal ven kompresif ultrasonografi (CUS) yüksek duyarlılığa sahiptir. Şüpheli PE durumunda ise normal akciğer grafisini takiben ventilasyon/perfüzyon (V/Q) taraması veya bilgisayarlı tomografi pulmoner anjiyografi (BTPA) tercih edilir. Tedavide ve önlemede, plasentayı geçmeyen ve fetüs için güvenli olan düşük moleküler ağırlıklı heparin (DMAH) ve anfraksiyone heparin (AFH) öncelikli olarak kullanılır. Buna karşın, teratojenik etkileri ve veri yetersizliği nedeniyle varfarin ve direkt oral antikoagülanlar gebelikte kontrendikedir. Heparin tedavisi kanama, heparine bağlı trombositopeni (HIT), cilt nekrozu ve osteoporoz gibi ciddi komplikasyonlara yol açabilir. Doğum zamanı öngörülebiliyorsa, nöraksiyel anestezi sırasında spinal hematom riskini önlemek amacıyla DMAH tedavisi doğumdan en az 24 saat önce kesilmelidir. Antikoagülasyonun kontrendike olduğu durumlarda inferior vena kava filtreleri veya hayatı tehdit eden vakalarda trombolitik tedavi değerlendirilebilir.

Pregnancy and the postpartum period are critical processes that increase the risk of venous thromboembolism (VTE) by 4-50 times, with deep vein thrombosis (DVT) occurring three times more frequently than pulmonary embolism (PE). PE ranks as the seventh leading cause of maternal mortality in developed countries. In the postpartum period, the risk of VTE is highest during the first six weeks. Inherited thrombophilia, a history of previous VTE, cesarean delivery, obesity, and advanced maternal age are among the primary risk factors. Compression ultrasonography (CUS) of proximal veins yields high sensitivity in diagnosing DVT during pregnancy. For suspected PE, a ventilation/perfusion (V/Q) scan or computed tomography pulmonary angiography (CTPA) is preferred following a normal chest X-ray. Low-molecular-weight heparin (LMWH) and unfractionated heparin (UFH), which do not cross the placenta and are safe for the fetus, are primarily utilized for treatment and prophylaxis. Conversely, warfarin and direct oral anticoagulants are contraindicated during pregnancy due to teratogenic effects and insufficient data. Heparin therapy may lead to severe complications such as bleeding, heparin-induced thrombocytopenia (HIT), skin necrosis, and osteoporosis. If the timing of delivery is predictable, LMWH therapy must be discontinued at least 24 hours prior to delivery to prevent the risk of spinal hematoma during neuraxial anesthesia. Inferior vena cava filters can be considered when anticoagulation is contraindicated, or thrombolytic therapy may be evaluated in life-threatening cases.

Referanslar

Marik PE, Plante LA. Venous thromboembolic disease and pregnancy. N Engl J Med 2008;359:2025.

Bourjeily G, Paidas M, Khalil H, et al. Pulmonary embolism in pregnancy. Lancet 2010;375:500.

Chang J, Elam-Evans LD, Berg CJ, et al. Pregnancy-related mortality surveillance-United States, 1991-1999. MMWR Surveill Summ. 2003;52:1.

Blondon M, Harrington LB, Righini M, et al. Racial and ethnic differences in the risk of postpartum venous thromboembolism: a population-based, case-control study. J Thromb Haemost. 2014;12:2002.

Simpson EL, Lawrenson RA, Nightingale Al, et al, Venous thromboembolism in pregnancy and the puerperium: incidence and additional risk factors from a London perinatal database. BJOG. 2001;108:56.

Sultan AA, Tata LJ, West J, et al. Risk factors for first venous thromboembolism around pregnancy: a population-based cohort study from the United Kingdom. Blood. 2013;121:3953.

Abdul Sultan A, West J, Tata LJ, et al. Risk of first venous thromboembolism in pregnant women in hospital: population based cohort study from England. BMJ. 2013;347:6099.

Zotz RB, Gerhardt A, Scharf RE. Inherited thrombophilia and gestational venous thromboembolism. Best Pract Res Clin Haematol. 2003;16:243.

Rutherford S, Montoro M, McGehe W, et al. Thromboembolic disease associated with pregnancy: an 11-year review. Am J Obstet Gynecol. 1991;64:286.

Kearon JA, Ginsberg JS, Hirsh J. The role of venous ultrasonography in the diagnosis of suspected deep venous thrombosis and pulmonary embolism. Ann Intern Med. 1998;129:1044.

Chan WS, Lee A, Spencer FA, et al. D-dimer testing in pregnant Patients: towards determining the next ‘level’ in the diagnosis of deep vein thrombosis. J Thromb Haemost. 2010;8:1004.

Macklon NS, Greer IA, Bowman AW, et al. An ultrasound study of gestational and postural changes in the deep venous system of the leg in pregnancy. Br J Obstet Gynaecol. 1997;104:191.

Wells PS, Hirsh J, Anderson DR, et al. Comparison of the accuracy of impedance plethysmography and compression ultrasonography in outpatients with clinically suspected deep vein thrombosis. A two centre paired-design prospective trial. Thromb Haemost. 1995;74:1423.

Chan WS, Spencer FA, Lee AY, et al. Safety of withholding anticoagulation in pregnant women with suspected deep vein thrombosis following negative serial compression ultrasound and iliac vein imaging. CMAJ. 2013;185:194.

Torkzad MR, Bremme K, Hellgren M, et al. Magnetic resonance imaging and ultrasonography in diagnosis of pelvic vein thrombosis during pregnancy. Thromb Res. 2010;126:107.

Bates SM, Jaeschke R, Stevens SM, et al. Diagnosis of DVT: Antithrombotic Theraphy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guİdelines. Chest. 2012;141:351.

Bates SM, Greer IA, Middeldorp S, et al. VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Theraphy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012,141:691.

American College of Obstetricians and Gynecologists Women’s Health Care Physicians. ACOG Practice Bulletin No.138: Inherited thrombophilias in pregnancy. Obstet Gynecol. 2013;122:706.

Bates SM, Rajasekhar A, Middeldorp S, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy. Blood Adv. 2018;2:317.

NICE (2020). Venous thromboembolic diseases: diagnosis, management and thrombophilia testing. (26/03/2020 tarihinde http://www.nice.org.uk/nicemedia/live/12695/47195/47195.pdf adresinden ulaşılmıştır).

Norgren L, Austrell C, Nilsson L. The efffect of graduated ealstic compression stockings on femoral blood flow velocity during late pregnancy. Vasa. 1995;24:282.

Gherman RB, Goodwin TM, Leung B, et al. Incidence, clinical characteristics, and timing of ocjectively diagnosed venous thromboembolism during pregnancy. Obstet Gynecol. 1999;94:730.

Goodacre S, Horspool K, Nelson-Piercy C, et al. The DİPEP study: an observational study of the diagnostic accuracy of clinical assessment, D-dimer and chest x-ray for suspected pulmonary embolism in pregnancy and postpartum. BJOG. 2019;126:383.

Powrie RO, Larson L, Rosene-Montella K, et al. Alveolar-arterial oxygen gradient in acute pulmonary embolism in pregnancy. Am J Obstet Gynecol. 1998;178:394.

Damodaram M, Kaladindi M, Luckit J, et al. D-dimers as a screening test for venous thromboembolism in pregnancy: is it of any use? J Obstet Gynaecol. 2009;29:101.

Gottschalk A, Stein PD, Goodman LR, et al. Overwiew of Prospective Investigation of Pulmonary Embolism Diagnosis II. Semin Nucl Med. 2002;32:173.

Leung AN, Bull TM, Jaeschke R, et al. An official American Thoracic Society/Society of Thorasic Radiology clinical practice guideline: evaluation of suspected pulmonary embolism in pregnancy. Am J Respir Crit Care Med. 2011;184:1200.

PIODED Investigators. Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIODED). JAMA. 1990;263:2753.

Cahill AG, Stout MJ, Macones GA, et al. Diagnosing pulmonary embolism in pregnancy using computed-tomographic angiography or ventilatio-perfusion. Obstet Gynecol. 2009;114:124.

Revel MP, Cohen S, Sanchez O, et al. Pulmonary embolism during pregnancy:diagnosis with lung scintigraphy or CT angiography? Radiology. 2011;258:590.

Shakir K, Goodman LR, Tali A, et al. Pulmonary embolism in pregnancy: CT pulmonary angiography versus perfusion scanning. AJR Am J Roentgenol. 2010;195:214.

U-King-Im JM, Freeman SJ, Boylan T, et al. Quality of CT pulmonary angiography for suspected pulmonary embolus in pregnancy. Eur Radiol. 2008;18:2709.

Meaney JF, Weg JG, Chenevert TL, et al. Diagnosis of pulmonary embolism with magnetic resonance angiography. N Engl J Med. 1997;336:1422.

Wittram C, Waltman AC, Shepard JA, et al. Discordance between CT and angiography in the PIODED II study. Radiology. 2007;244:883.

Chan WS, Rey E, Kent NE, et al. Venous thromboembolism and antithrombotic therapy in pregnancy. J Obstet Gynaecol Can. 2014;36:527.

RCOG (2021). Thromboembolic disease in pregnancy and the puerperium: Acute management. (06/03/2021 tarihinde http://www.rcog.org.uk/globalassets/documents/guidelines/gtg-37b.pdf adresinden ulaşılmıştır).

Konstantinides SV, Meyer G, Becattini C, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). Eur Respir J. 2019;54.

Cohen H, Arachchillage DR, Middledorp S, et al. Management of direct oral anticoagulants in women of childbearing potential: guidance from the SSC of the ISTH. J Thromb Haemost. 2016;14:1673.

Beyer-Westendorf J, Michalski F, Tittl L, et al. Pregnancy outcome in patients exposed to direct oral antikoagulants-and the challenge of event reporting. Thromb Haemost. 2016;116:651.

Dulitzki M, Pauzner R, Langevitz P, et al. Low-molecular-weight-heparin during pregnancy and delivery: preliminary experience with 41 pregnancies. Obstet Gynecol. 1996;87:380.

Milford W, Chadha Y, Lust K. Use of a retrievable inferior vena cava filter in term pregnancy: case report and review of literatüre. Aust N Z J Obstet Gynaecol. 2009;49:331.

Yayınlanan

4 Nisan 2022

Lisans

Lisans